Related Experiment Video
Updated: May 26, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Immunization schedule of the Spanish Association of Pediatrics: 2012 recommendations
D Moreno-Pérez1, F J Alvarez García, J Aristegui Fernández
1Spanish Association of Pediatrics Vaccines Advisory Committee, Spain. dmp.malaga@gmail.com
Insights
The Spanish Association of Pediatrics
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- The Advisory Committee on Vaccines (CAV-AEP) annually updates immunization schedules.
- Schedules consider epidemiological data, vaccine effectiveness, and efficiency.
- Vaccinations are categorized as routine, recommended, or for risk groups.
Purpose of the Study:
- To present the updated annual immunization schedule from the CAV-AEP.
- To outline key changes and recommendations for childhood vaccinations in Spain.
- To emphasize the importance of achieving a unified national immunization schedule.
Main Methods:
- Annual review of epidemiological data and vaccine evidence.
- Categorization of vaccines based on recommendation levels (routine, recommended, risk group).
- Analysis of current epidemiological trends to inform schedule adjustments.
Main Results:
- MMR and varicella vaccines: first dose at 12 months (12-15 months), second dose at 2-3 years.
- Tdap vaccine: first dose at 4-6 years, second dose at 11-14 years.
- Recommendations for increased HPV vaccination coverage, routine pneumococcal, universal varicella, and rotavirus vaccination.
- Emphasis on vaccinating at-risk groups for influenza and hepatitis A, and catch-up immunizations.
Conclusions:
- The updated schedule incorporates new epidemiological insights and vaccine data.
- Key changes include adjusted timings for MMR, varicella, and Tdap vaccines.
- Continued emphasis on universal vaccination for preventable diseases and addressing vaccination gaps.
Abstract:
The Advisory Committee on Vaccines of the Spanish Association of Pediatrics (CAV-AEP) updates the immunization schedule every year, taking into account epidemiological data as well as evidence on the effectiveness and efficiency of vaccines. The present schedule includes grades of recommendation. We have graded as routine vaccinations those that the CAV-AEP believes all children should receive; as recommended those that fit the profile for universal childhood immunization and would ideally be given to all children, but that can be prioritized according to the resources available for their public funding; and as risk group vaccinations those that specifically target individuals in situations of risk. Immunization schedules tend to be dynamic and adaptable to ongoing epidemiological changes. Nevertheless, the achievement of a unified immunization schedule in all regions of Spain is a top priority for the CAV-AEP. Based on the latest epidemiological trends, the main changes introduced to the schedule are the administration of the first dose of the MMR and the varicella vaccines at age 12 months (12-15 months) and the second dose at age 2-3 years, as well as the administration of the Tdap vaccine at age 4-6 years, always followed by another dose at 11-14 years of age. The CAV-AEP believes that the coverage of vaccination against human papillomavirus in girls aged 11-14 years must increase. It reasserts its recommendation to include vaccination against pneumococcal disease in the routine immunization schedule. Universal vaccination against varicella in the second year of life is an effective strategy and therefore a desirable objective. Vaccination against rotavirus is recommended in all infants due to the morbidity and elevated healthcare burden of the virus. The Committee stresses the need to vaccinate population groups considered at risk against influenza and hepatitis A. Finally, it emphasizes the need to bring incomplete vaccinations up to date following the catch-up immunization schedule.
Related Concept Videos
Vaccinations
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism

